Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

February 28, 2003

Study Completion Date

February 28, 2003

Conditions
Asthma
Interventions
DRUG

anti-IL-4 monoclonal antibody (pascolizumab)

Trial Locations (18)

18045

Valley Clinical Research Center, Easton

53792

University of Wisconsin Medical School, Madison

55402

Clinical Research Institute, Minneapolis

61761

ICSL Clinical Studies, Normal

63141

The Clinical Research Center, LLC, St Louis

68131

Center for Allergy, Asthma and Immunology, Creighton University, Omaha

77090

Clinical Trials North Houston, Houston

80206

National Jewish Medical and Research Center, Denver

90025

Allergy Research Foundation, Los Angeles

92120

Allergy Associates Medical Group, Inc., San Diego

92691

Southern California Research, Mission Viejo

92868

Clinical Trials of Orange Cnty., Inc., Orange

95117

Allergy and Asthma Associates Santa Clara Valley Research Center, San Jose

95207

Bensch Research Associates, Stockton

97035

Allergy, Asthma, and Dermatology Research Center, LLC, Lake Oswego

02115

Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital, Boston

02747

New England Clinical Studies, North Dartmouth

08540

Princeton Center for Clinical Research, Princeton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Facet Biotech

INDUSTRY